Nov 10 2022
A new study provides evidence “supporting efficacy and tolerability of a full-spectrum, high-CBD product for anxiety.” Published in the journal Communications Medicine and conducted by researchers at Harvard Medical School, the study is titled Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial. The study …
Oct 19 2022
The findings of a new study “indicate that CBD might be beneficial in alleviating UVB-induced skin damage in humans.” The study was published in the peer-reviewed journal Molecules, and was epublished by the U.S. National Institute of Health. It was conducted by researchers at Sichuan University in China. “Cannabidiol (CBD) has emerged as a phytocannabinoid …
Oct 18 2022
A new study being published in the journal Pharmacological Reports has found that the marijuana compound cannabidiol (CBD) is effective against brainstem and limbic seizures. “Cannabidiol (CBD) has been of rapidly growing interest in the epilepsy research field due to its antiseizure properties in preclinical models and patients with pharmacoresistant epilepsy”, states the study, which …
